ClinicalTrials.Veeva

Menu

Validation of the Catquest-9SF Questionnaire in Greek Language

D

Democritus University of Thrace

Status

Completed

Conditions

Cataract
Catquest-9SF

Treatments

Diagnostic Test: Demographics and clinical parameters
Diagnostic Test: Catquest-9SF questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT05323526
ES1/Th7/30-01-2020

Details and patient eligibility

About

Primary objective of this study is the validation of the Catquest-9SF questionnaire in the Greek population.

Full description

The present study aims to validate the Catquest-9SF questionnaire in the Greek population. The Catquest-9SF is a questionnaire for assessing the quality of vision of patients with cataract. It consists of 9 questions, two of which concern the subjective assessment of the patient's vision and the other seven the patient's ability to perform various daily activities.

The Catquest-9SF questionnaire were translated into the Greek language by a translation team consisting of five members: one translation coordinator, two professional native English-speaking translators, one professional native Greek-speaking translator and one native Greek ophthalmologist fluent in English.

Patients participating in the study are asked to complete a questionnaire in Greek before and after cataract surgery. Upon completion of the data collection, data are processed and analyzed through Rasch analysis to determine whether the questionnaire can be used in clinical practice in this translated version.

The following clinical parameters are evaluated: age, gender, preoperative and postoperative monocular distance uncorrected visual acuity (UVA), distance best spectacle-corrected visual acuity (BSCVA) of the eye for cataract surgery, binocular distance UVA and BSCVA, refraction, spherical equivalent (SE), and intraocular pressure.

Enrollment

100 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with unilateral or bilateral senile cataract with stage 2 nuclear opalescence according to the Lens Opacities Classification System III (LOCS-3) grading scale, and no severe cognitive impairment during their preoperative examination.

Exclusion criteria

  • Patients with difficulty with the Greek language or dementia, Alzheimer's disease, severe stroke with mental disorder and conditions with the onset of mental retardation.

Trial design

100 participants in 1 patient group

Study Group
Description:
100 patients who will undergo cataract surgery
Treatment:
Diagnostic Test: Catquest-9SF questionnaire
Diagnostic Test: Demographics and clinical parameters

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems